French biotech Bionyra raises 143 million euros for drug development
French biotech Bionyra announces a 143-million-euro funding round to support its growth.
Published 7sem1 sourceNotable
Lire en français
≈ 18s
The fact
The capital will enable the company to accelerate drug development for targeted diseases.
Bionyra now ranks among France's leading emerging biotechnology companies.
Click the link to read an article on the topic: